CurrentPremera BluecrossPolicy 3.01.515

Behavioral Health: Residential/Sub-Acute Withdrawal Management (Detoxification)

Customize your policy alerts

Sign up for Premera Bluecross Policy 3.01.515 alerts

Get alerted when Policy 3.01.515 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs when residential or sub-acute withdrawal management for substance use disorders may be considered medically necessary in specified residential, hospital-unit, psychiatric residential, or stand-alone withdrawal management facilities.

Policy Summary

PayerPremera Bluecross

PolicyBehavioral Health: Residential/Sub-Acute Withdrawal Management (Detoxification)

Policy CodePolicy 3.01.515

Change TypeTerminology and reference clarificationno material coverage change

Effective DateOctober 1, 2026

Last ReviewSep 21, 2026

Next Review DateNot specified

Key ActionDocument the admission evaluation within one day after admission and subsequent daily evaluations of medical status, withdrawal symptoms, medications, and continued treatment needs.

SourceLink

POLICY UPDATE CHANGES

Terminology was revised from residential/sub-acute detoxification to residential/sub-acute withdrawal management (detoxification).

The policy added an explanation supporting 24/7 nursing observation when active medical management is provided.

The References section added the Fourth Edition of the ASAM criteria for adolescents and transition-aged youth.

24/7Nursing observation

DailyClinician evaluation

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentPremera BluecrossPolicy 3.01.515

Behavioral Health: Residential/Sub-Acute Withdrawal Management (Detoxification)

Customize your policy alerts

Sign up for Premera Bluecross Policy 3.01.515 alerts

Get alerted when Policy 3.01.515 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerPremera Bluecross

PolicyBehavioral Health: Residential/Sub-Acute Withdrawal Management (Detoxification)

Policy CodePolicy 3.01.515

Change TypeTerminology and reference clarificationno material coverage change

Effective DateOctober 1, 2026

Last ReviewSep 21, 2026

Next Review DateNot specified

Key ActionDocument the admission evaluation within one day after admission and subsequent daily evaluations of medical status, withdrawal symptoms, medications, and continued treatment needs.

SourceLink

POLICY UPDATE CHANGES

Terminology was revised from residential/sub-acute detoxification to residential/sub-acute withdrawal management (detoxification).

The policy added an explanation supporting 24/7 nursing observation when active medical management is provided.

The References section added the Fourth Edition of the ASAM criteria for adolescents and transition-aged youth.

24/7Nursing observation

DailyClinician evaluation

Admission evaluation and medication deadline

96 hoursAlcohol or benzodiazepine risk window

5 daysSecondary Review threshold

Medical Necessity Coverage Criteria

Initial admission medical necessity

Residential and sub-acute withdrawal management may be considered medically necessary when the qualifying setting and all symptom criteria are met.

Admission medical necessity

Qualifying treatment setting: Care is provided in a stand-alone substance use disorder or dual-disorders residential or sub-acute treatment facility; psychiatric residential treatment facility; substance use disorder or dual-disorders residential treatment unit in a general hospital; or stand-alone withdrawal management facility.
A stand-alone withdrawal management facility is sub-acute unless licensed as a hospital.
Symptom criteria
- Substance use disorder: The substance use disorder is moderate or severe, is other than tobacco/nicotine, and is not in remission.Moderate or severe; not tobacco/nicotine; not in remission
- Withdrawal risk: The substance or substances in use have withdrawal syndromes that may be moderate, severe, potentially life-threatening, capable of causing serious physical harm, or physically so intolerable that withdrawal is highly unlikely to be completed without 24/7 containment; and continuous use is such that discontinuation without active medical monitoring and management will produce withdrawal at that level of severity.
  Simple or less severe physical or mental discomfort does not qualify as physically intolerable withdrawal.
- Qualifying withdrawal presentation or history
  - Current or imminent serious withdrawal: Current signs or symptoms of moderate, severe, or potentially life-threatening withdrawal; signs or symptoms indicating that such withdrawal is imminent without active medical management; or a recent/frequent use pattern and amount making such withdrawal highly likely with discontinuation without active medical management.
  - Prior serious withdrawal: Previous moderate, severe, or life-threatening withdrawal from the same or similar substances with a similar use pattern.
  - Current or imminent physically intolerable withdrawal: Current signs or symptoms of physically severely intolerable withdrawal; signs or symptoms indicating that it is imminent without active medical management; or a recent/frequent use pattern and amount making it highly likely with discontinuation without active medical management.
  - Prior physically intolerable withdrawal: Previous physically severely intolerable withdrawal from the same or similar substances with a similar use pattern.

Continued stay symptom criteria

At least one of the following must be present for continued stay.

Ongoing serious withdrawal: Continued signs or symptoms indicate that moderate, severe, or potentially life-threatening withdrawal is likely without ongoing active medical management.
Ongoing physically intolerable withdrawal: Continued signs or symptoms of physically severely intolerable withdrawal, or signs or symptoms indicating that it is likely without ongoing active medical management.
Mild or absent withdrawal observation window: Mild or no withdrawal signs and symptoms are present for a maximum of one full day, followed by discharge if moderate or severe withdrawal signs or symptoms do not recur.Maximum one full day
This is the limited period before discharge when symptoms are mild or absent.

Intervention criteria

ALL of the following intervention requirements must be present for admission and continued stay.

Intervention criteria for admission and continued stay

Medical evaluation: A physician, nurse practitioner, or physician assistant conducts an admission evaluation, including medical history, withdrawal signs and symptoms, and physical examination, within one day after admission; the patient is subsequently evaluated at least daily for medical status, withdrawal signs and symptoms, medication regimen, and other continued treatment needs, in person or by telehealth.Within 1 day after admission; then at least daily
Substance use evaluation: The substance use evaluation is completed during the first day of admission.First day of admission
Withdrawal medication: Medication to manage or prevent withdrawal symptoms is started during the first day of admission.

Residential/sub-acute withdrawal management requirements

All of the following must be present.

Admission and ongoing clinician evaluation: A physician, nurse practitioner, or physician assistant conducts an admission evaluation within one day after admission, including medical history, withdrawal signs and symptoms, and physical examination; the patient is then evaluated at least once every day, in person or by telehealth, for medical status, withdrawal signs and symptoms, medication regimen, and other continued treatment needs.Within 1 day after admission; then at least daily
A licensed psychologist may perform attending-clinician services where legally permitted by state licensure.
Substance-use evaluation: A substance-use evaluation is completed during the first day of admission.First day of admission
Withdrawal medication: Medication to manage or prevent withdrawal symptoms is started during the first day of admission.

Discontinuation of withdrawal medication

Withdrawal medication may be discontinued only when one of the following alternatives is met.

Permitted discontinuation of withdrawal medication

Symptoms mild or resolved: Withdrawal symptoms have become mild or have resolved, and discharge is planned for and occurs no later than one day after withdrawal symptoms have been mild or absent for one full day.Discharge no later than 1 day after 1 full day of mild or absent symptoms
Confirmation medication is no longer needed: Before discharge, the facility confirms that withdrawal medication is no longer needed, and discharge is planned for and occurs the day after medication is discontinued without recurrence of moderate or severe withdrawal symptoms.Discharge the day after medication discontinuation
Moderate or severe withdrawal symptoms must not recur.

Residential and sub-acute withdrawal management is not medically necessary when the patient is only being observed for possible withdrawal signs or symptoms without active medical management. Social observation alone does not meet the policy’s medical-necessity standard.

Continued residential or sub-acute withdrawal management is not medically necessary when the stay is based only on post-acute withdrawal syndrome, incomplete discharge planning, waiting for a residence or treatment placement, inadequate family, living, peer, or community support, or patient or family noncompliance. Continued care must instead meet the applicable symptom and intervention criteria; after a first compliance infraction, one additional opportunity may be considered in some circumstances.

Residential or sub-acute withdrawal management is not medically necessary when provided in a halfway house or sober living residence, wilderness or adventure/camping program or expedition, boarding or therapeutic boarding school, boot camp, military school or academy, group home, therapeutic home, or supported or alternative housing.

Admission is not medically necessary when it is based solely on a programmatic requirement or standard procedure that all patients undergo withdrawal management before residential treatment. Medical necessity must be established by the patient’s clinical withdrawal risk and the required active medical-management interventions.

Operational Timing Rules

Alcohol or benzodiazepine withdrawal monitoring window

Applicable substancesAlcohol or benzodiazepines

Monitoring windowLess than 96 hours or 4 days since last reported use

Undocumented last-use timeUse 4 days as the closest approximation when the time of last use is not documented

Mild or absent withdrawal before discharge

Withdrawal statusMild or no withdrawal signs and symptoms

Maximum observation periodOne full day

Discharge condition

Documentation and Review Requirements

Documentation Required

Complete the Admission Medical Evaluation

Document an admission evaluation completed by a physician, nurse practitioner, or physician assistant within one day after admission. Include the medical history, withdrawal signs and symptoms, and physical examination.

The admission evaluation must be completed within one day after admission.
Include medical history, documentation of withdrawal signs and symptoms, and a physical examination.

Documentation Required

Document Admission Symptom Criteria

Document a qualifying substance use disorder and the clinical basis for withdrawal-management admission. The record must establish the substance-use pattern and the current, imminent, or highly likely withdrawal severity requiring 24/7 containment and active medical management.

Substance use disorder must be moderate or severe, involve a substance other than tobacco/nicotine, and not be in remission.
Document continuous use and the substance-specific withdrawal syndrome, including whether withdrawal may be moderate, severe, potentially life-threatening, capable of causing serious physical harm, or physically intolerable without 24/7 containment.

Withdrawal Management Overview

Withdrawal management is the medically monitored process of stopping substance use while managing potentially uncomfortable, dangerous, or life-threatening withdrawal symptoms. In this policy, residential and sub-acute withdrawal management are synonymous and may also be referred to as ASAM Level 3.7-WM. Covered withdrawal management is distinguished from social observation or supportive-only programs by active medical management, medication when indicated, medical evaluation, and 24/7 nursing observation.

Key Policy Definitions

Residential and sub-acute withdrawal management

Synonymous termsResidential withdrawal management and sub-acute withdrawal management

Alternate terminologyResidential and sub-acute withdrawal management (detoxification)

ASAM levelASAM Level 3.7-WM

ASAM edition specifiedThird Edition of the ASAM Criteria

Stand-alone withdrawal management facility

Default classificationSub-acute withdrawal management

Facility typeStand-alone withdrawal management facility

Residential and Sub-Acute Withdrawal Management

Residential/Sub-acute withdrawal management (ASAM Level 3.7-WM)

ASAM Level 3.7-WM is the residential/sub-acute withdrawal management level described by this policy. Admission requires the qualifying clinical presentation and the required medically managed interventions.

Residential/sub-acute withdrawal management admission

Qualifying setting: Care is provided in an eligible residential, psychiatric residential, general-hospital residential treatment unit, sub-acute, or stand-alone withdrawal management facility.
A stand-alone withdrawal management facility is sub-acute unless licensed as a hospital.
Required clinical presentation: The substance use disorder and withdrawal-risk criteria are met, with at least one qualifying current, imminent, highly likely, or prior serious or physically severely intolerable withdrawal condition.
Required interventions:

Policy Summary

PayerPremera Bluecross

PolicyBehavioral Health: Residential/Sub-Acute Withdrawal Management (Detoxification)

Policy CodePolicy 3.01.515

Change TypeTerminology and reference clarificationno material coverage change

Effective DateOctober 1, 2026

Last ReviewSep 21, 2026

Next Review DateNot specified

Key ActionDocument the admission evaluation within one day after admission and subsequent daily evaluations of medical status, withdrawal symptoms, medications, and continued treatment needs.

SourceLink

On This Page

Alcohol or benzodiazepine withdrawal risk window: Mild withdrawal signs and symptoms from alcohol or benzodiazepine withdrawal are present with active medical management, and fewer than 96 hours or 4 days have elapsed since last reported use.Less than 96 hours or 4 days since last use

Delirium tremens can begin up to 96 hours after last use even when symptoms are mild. If last use is undocumented, use 4 days as the closest approximation.

First day of admission

Active medical management continues throughout the stay, except that withdrawal medication may be discontinued under a qualifying discharge pathway.

Discontinuation is permitted when symptoms are mild or resolved with timely discharge, or to confirm before discharge that medication is no longer needed without recurrence of moderate or severe symptoms.

Nursing observation: Nursing staff observation is provided continuously.24/7

Discharge planning starts within one day after admission.Within 1 day after admission

First day of admission

Active medical management continues throughout the stay.Throughout the stay

Withdrawal medication may be discontinued only under the specified discharge-related conditions.

Nursing observation: Nursing staff observation is provided continuously.24/7

Discharge planning starts within one day after admission.Within 1 day after admission

Discharge if moderate or severe withdrawal signs or symptoms do not recur

Document at least one qualifying indicator: current withdrawal; withdrawal imminent without active medical management; a recent/frequent use pattern making qualifying withdrawal highly likely; a comparable prior withdrawal history; or current, imminent, highly likely, or prior physically severely intolerable withdrawal.

Documentation Required

Complete Initial Substance-Use and Medication Evaluation

Complete and document the substance-use evaluation during the first day of admission. Start medication to manage or prevent withdrawal symptoms during that same first day and record the medication initiation.

Substance-use evaluation: first day of admission.
Withdrawal-management medication: initiate during the first day of admission.

Documentation Required

Maintain Active Medical Management

Maintain active medical management throughout the stay and document the clinical response and rationale for any medication changes or discontinuation. If medication is discontinued, document that the applicable symptom and discharge-timing requirements are met.

Document medications, their effects, changes to the regimen, examinations, and ongoing clinical monitoring.
Medication may be discontinued when withdrawal is mild or resolved and discharge is planned for and occurs no later than one day after symptoms have been mild or absent for one full day.
Medication may also be discontinued to confirm it is no longer needed; discharge must be planned for and occur the next day if moderate or severe withdrawal does not recur.

Documentation Required

Document Alcohol or Benzodiazepine Timing

For mild alcohol or benzodiazepine withdrawal, document active medical management and the time since the patient’s last reported use. Continued care under this criterion is limited to less than 96 hours, or four days, since last use.

Document the last reported use of alcohol or a benzodiazepine.
If the last-use time is not documented, use four days as the closest approximation for the 96-hour calculation.
Delirium tremens may begin up to 96 hours after last use even when withdrawal signs and symptoms are mild.

Documentation Required

Start Discharge Planning Early

Begin discharge planning within one day after admission and document the plan throughout the stay. When withdrawal medication is discontinued, document the required discharge timing and ensure discharge occurs as planned if qualifying withdrawal does not recur.

Discharge planning must start within one day after admission.
Discharge must occur no later than one day after withdrawal symptoms have been mild or absent for one full day when medication is discontinued on that basis.
When medication is discontinued to confirm it is no longer needed, discharge must occur the following day absent recurrence of moderate or severe withdrawal.

Documentation Required

Complete Admission and Daily Clinical Evaluations

Ensure an attending clinician performs the admission assessment and evaluates the patient at least daily. Each subsequent evaluation may be in person or by telehealth and must address medical status, withdrawal signs and symptoms, the medication regimen, and continued treatment needs.

Admission evaluation: physician, nurse practitioner, or physician assistant within one day after admission.
Daily evaluations must assess medical status, withdrawal signs and symptoms, medication regimen, and other continued treatment needs.
A licensed psychologist may serve as attending clinician where permitted by state licensure, but must perform all attending-clinician services and provide active medical management.

Documentation Required

Document the Substance-Use Evaluation

Complete and document the substance-use evaluation during the first day of admission.

Record the evaluation in the admission documentation.

Documentation Required

Document Ongoing Medical Management

Document active medical management throughout the stay, including medications, their effects and changes, examinations, and clinical monitoring. The record should show that treatment is directed at managing or preventing withdrawal rather than observation alone.

Document the medication regimen and patient response.
Document medication changes, physical examinations, medical status, withdrawal signs and symptoms, and ongoing monitoring.
Continue active medical management throughout the stay unless the policy’s medication-discontinuation conditions are met.

Documentation Required

Provide Nursing Observation and Start Discharge Planning

Provide and document nursing-staff observation 24/7. Begin discharge planning within one day after admission and maintain documentation of the plan, including the discharge timing required when withdrawal medication is discontinued.

Nursing observation must be continuous, 24 hours a day, 7 days a week.
Discharge planning must start within one day after admission.
Document the discharge plan and ensure discharge occurs within the applicable one-day timeframe after symptoms are mild or absent for a full day or after medication is discontinued for confirmation.

Unsupported block type: denial_risk

Unsupported block type: prior_auth

Hospital exceptionThe classification is inpatient withdrawal management when the facility is licensed as a hospital

Active medical management

Medication useDaily use of medication(s) to treat or prevent withdrawal symptoms

Medication-effect evaluationEvaluate medication effects at least once daily, with dose adjustments or medication changes when indicated

Physical examinationPerform appropriate physical-examination components at least once daily and more often when indicated

Vital signsMonitor vital signs when indicated

Laboratory testingPerform laboratory testing appropriate to the withdrawal or potential withdrawal syndrome when indicated

ExclusionObservation for possible withdrawal without these components does not constitute active medical management

Attending clinician

Permitted roleA licensed psychologist may serve as the attending clinician

State requirementOnly in states where that function for substance-use-disorder residential treatment is within the psychologist’s legally permitted scope of licensure

Required responsibilitiesThe psychologist must perform all attending-clinician services noted in the policy and provide active medical management

Admission evaluation, substance-use evaluation, withdrawal medication, active medical management, 24/7 nursing observation, and discharge planning are provided as required.

Evaluation and medication during first day; nursing observation 24/7

Continued stay

Serious or physically intolerable withdrawal: Continued signs or symptoms indicate that serious or physically severely intolerable withdrawal is present or likely without ongoing active medical management.
Alcohol or benzodiazepine risk window: Mild withdrawal signs and symptoms are present with active medical management and fewer than 96 hours or 4 days have elapsed since last reported use.Less than 96 hours or 4 days since last use
Limited mild or absent symptom period: Mild or no withdrawal signs and symptoms have been present for no more than one full day, followed by discharge if moderate or severe symptoms do not recur.Maximum one full day before discharge

Residential/Sub-Acute Withdrawal Management (Detoxification)

Residential/sub-acute withdrawal management (detoxification) requires the following level-of-care elements for admission, continued stay, and discharge.

Residential withdrawal management admission requirements: The admission and treatment requirements stated in the policy must be met, including timely attending-clinician evaluation, substance-use evaluation, initiation of withdrawal medication, active medical management, continuous nursing observation, and prompt discharge planning.Evaluation and medication during first day; nursing observation 24/7

Continued residential withdrawal management: Active medical management continues throughout the stay, with daily clinician evaluation and 24/7 nursing observation.Daily evaluation; 24/7 nursing

Continued stays beyond 5 days should be referred for Secondary Review.

Withdrawal medication discontinuation and discharge: Discharge follows either the pathway for mild or resolved withdrawal symptoms or the pathway confirming that withdrawal medication is no longer needed without recurrence of moderate or severe symptoms.Within the specified 1-day discharge windows